{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T14:28:22Z","timestamp":1758637702415},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1097\/coc.0b013e318145b9db","type":"journal-article","created":{"date-parts":[[2007,12,7]],"date-time":"2007-12-07T08:01:55Z","timestamp":1197014515000},"page":"601-606","source":"Crossref","is-referenced-by-count":20,"title":["Clinical Presentation and Outcomes of Lymphocyte-predominant Hodgkin Disease at the University of Florida"],"prefix":"10.1097","volume":"30","author":[{"given":"Bhishamjit S.","family":"Chera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Olivier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher G.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James W.","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy P.","family":"Mendenhall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-7-20210128","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1200\/JCO.1999.17.12.3835","article-title":"World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.","volume":"17","author":"Harris","year":"1999","journal-title":"J Clin Oncol"},{"key":"R3-7-20210128","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/1097-0142(196603)19:3<317::AID-CNCR2820190304>3.0.CO;2-O","article-title":"Natural history of Hodgkin's disease as related to its pathologic picture.","volume":"19","author":"Lukes","year":"1966","journal-title":"Cancer"},{"key":"R4-7-20210128","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/1097-0142(19830615)51:12<2293::AID-CNCR2820511221>3.0.CO;2-X","article-title":"Hodgkin's disease, lymphocytic predominance nodular. Increased risk for subsequent non-Hodgkin's lymphomas.","volume":"51","author":"Miettinen","year":"1983","journal-title":"Cancer"},{"key":"R5-7-20210128","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1200\/JCO.1999.17.3.776","article-title":"Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European task force on lymphoma project on lymphocyte predominant Hodgkin's disease.","volume":"17","author":"Diehl","year":"1999","journal-title":"J Clin Oncol"},{"key":"R6-7-20210128","article-title":"SAS OnlineDoc\u00ae. Version 8.","year":"1999"},{"key":"R7-7-20210128","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations.","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"R8-7-20210128","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1200\/JCO.1989.7.9.1303","article-title":"A comparative study of the nodular and diffuse variants of lymphocyte-predominant Hodgkin's disease.","volume":"7","author":"Borg-Grech","year":"1989","journal-title":"J Clin Oncol"},{"key":"R9-7-20210128","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1200\/JCO.1990.8.12.1959","article-title":"Clinical correlates of distinct immunophenotypic and histologic subcategories of lymphocyte-predominance Hodgkin's disease.","volume":"8","author":"Tefferi","year":"1990","journal-title":"J Clin Oncol"},{"key":"R10-7-20210128","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0360-3016(94)E0136-8","article-title":"Lymphocyte predominant Hodgkin's disease: a clinicopathologic comparative study of histologic and immunophenotypic subtypes.","volume":"31","author":"Crennan","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R11-7-20210128","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/1097-0142(19870101)59:1<99::AID-CNCR2820590122>3.0.CO;2-J","article-title":"Lymphocyte predominance Hodgkin's disease. A clinicopathologic reassessment.","volume":"59","author":"Trudel","year":"1987","journal-title":"Cancer"},{"key":"R12-7-20210128","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1200\/JCO.1997.15.9.3060","article-title":"Clinical presentation and outcome in lymphocyte-predominant Hodgkin's disease.","volume":"15","author":"Bodis","year":"1997","journal-title":"J Clin Oncol"},{"key":"R13-7-20210128","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1002\/cncr.21303","article-title":"Long-term outcome after radiotherapy alone for lymphocyte-predominant Hodgkin lymphoma: a retrospective multicenter study of the Australasian Radiation Oncology Lymphoma Group.","volume":"104","author":"Wirth","year":"2005","journal-title":"Cancer"},{"key":"R14-7-20210128","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0360-3016(98)00389-7","article-title":"Hodgkin's disease with lymphocyte predominance: long-term results based on current histopathologic criteria.","volume":"43","author":"Ha","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R15-7-20210128","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1002\/cncr.10404","article-title":"European organization for research and treatment of cancer and groupe d'Etude des Lymphomes de l'Adulte very favorable and favorable, lymphocyte-predominant Hodgkin disease.","volume":"94","author":"Wilder","year":"2002","journal-title":"Cancer"},{"key":"R16-7-20210128","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/oxfordjournals.annonc.a059244","article-title":"Nodular type of lymphocyte predominant Hodgkin's disease. A clinical study of 50 cases.","volume":"6","author":"Pappa","year":"1995","journal-title":"Ann Oncol"},{"key":"R17-7-20210128","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0167-8140(84)80001-8","article-title":"Lymphocyte predominant Hodgkin's disease: clinical presentation and results of treatment.","volume":"1","author":"Russell","year":"1984","journal-title":"Radiother Oncol"},{"key":"R18-7-20210128","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1056\/NEJM198801283180404","article-title":"Nodular and diffuse types of lymphocyte predominance Hodgkin's disease.","volume":"318","author":"Regula","year":"1988","journal-title":"N Engl J Med"},{"key":"R19-7-20210128","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/annonc\/3.suppl_4.S117","article-title":"Second cancer after the treatment for Hodgkin's disease: a report from the International Database on Hodgkin's Disease.","volume":"3","author":"Henry-Amar","year":"1992","journal-title":"Ann Oncol"},{"issue":"suppl 2","key":"R20-7-20210128","first-page":"83","article-title":"Non-Hodgkin's lymphoma arising in patients treated for Hodgkin's disease in the BNLI: a 20-year experience. British National Lymphoma Investigation.","volume":"2","author":"Bennett","year":"1991","journal-title":"Ann Oncol"},{"key":"R21-7-20210128","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1200\/JCO.2003.01.079","article-title":"Lymphocyte-predominant Hodgkin's lymphoma in children: therapeutic abstention after initial lymph node resection\u2014a study of the French society of pediatric oncology.","volume":"21","author":"Pellegrino","year":"2003","journal-title":"J Clin Oncol"},{"key":"R22-7-20210128","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1097\/00043426-200309000-00003","article-title":"Results of little or no treatment for lymphocyte-predominant Hodgkin disease in children and adolescents.","volume":"25","author":"Murphy","year":"2003","journal-title":"J Pediatr Hematol Oncol"},{"key":"R23-7-20210128","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1093\/annonc\/mdi323","article-title":"Extended field radiotherapy, combined modality treatment or involved field radiotherapy for patients with stage IA lymphocyte-predominant Hodgkin's lymphoma: a retrospective analysis from the German Hodgkin Study Group (GHSG).","volume":"16","author":"Nogova","year":"2005","journal-title":"Ann Oncol"}],"container-title":["American Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00000421-200712000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T05:50:05Z","timestamp":1618033805000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000421-200712000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/coc.0b013e318145b9db","relation":{},"ISSN":["0277-3732"],"issn-type":[{"value":"0277-3732","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}